Fang, Hu
Yan, Helen H. N.
Bilardi, Rebecca A.
Flensburg, Christoffer
Yang, Haocheng
Barbour, Jayne A.
Siu, Hoi Cheong
Turski, Michelle
Chew, Edward
Xu, Zhen
Lam, Siu T.
Sharma, Rakesh
Xu, Mengya
Li, Junshi
Ip, Ho W.
Cheung, Carol Y. M.
Huen, Michael S. Y.
Sweet-Cordero, E. Alejandro
Majewski, Ian J.
Leung, Suet Y.
Wong, Jason W. H. http://orcid.org/0000-0003-2953-7728
Funding for this research was provided by:
Research Grants Council, University Grants Committee (17100920, C7028-19G, T12-710/16-R)
Innovation and Technology Commission - Hong Kong
Article History
Received: 1 July 2022
Accepted: 20 October 2022
First Online: 31 October 2022
Declarations
:
: This study was approved by the Institutional Review Board (IRB) of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW14-257 and UW18-599) and by the Human Research Ethics Committees from the Walter & Eliza Hall Institute (project 13/01) and Melbourne Health (project 2012.274). All patients involved consented to the use of clinical information and tissue for research. In accordance with the IRB approvals, all the research conducted conformed to the principles of the Helsinki Declaration.
: Not applicable.
: SYL has received research sponsorship from Pfizer, Merck, Servier, and Curegenix. The remaining authors declare that they have no competing interests.